Twist Bioscience Cash from Financing (Quarterly) Analysis

Twist Bioscience Corp (TWST)

40.56 -1.91 (-4.50%) USD | NASDAQ | Nov 14, 12:24

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
June 30, 2024	2.908M
March 31, 2024	1.828M
December 31, 2023	-1.473M
September 30, 2023	0.442M
June 30, 2023	-0.661M
March 31, 2023	1.525M
December 31, 2022	-0.395M
September 30, 2022	1.24M
June 30, 2022	-1.311M
March 31, 2022	271.62M
December 31, 2021	-1.011M
September 30, 2021	1.575M
June 30, 2021	-0.765M
March 31, 2021	1.451M

Date	Value
December 31, 2020	326.92M
September 30, 2020	5.574M
June 30, 2020	108.06M
March 31, 2020	188.04M
December 31, 2019	2.057M
September 30, 2019	2.928M
June 30, 2019	84.28M
March 31, 2019	-1.634M
December 31, 2018	73.00M
September 30, 2018	6.583M
June 30, 2018	24.83M
March 31, 2018	54.75M
December 31, 2017	2.662M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-1.473M

Minimum

Dec 2023

326.92M

Maximum

Dec 2020

47.77M

Average

1.525M

Median

Mar 2023

Cash from Financing (Quarterly) Benchmarks

Perspective Therapeutics Inc	122.08M
Retractable Technologies Inc	-0.1329M
InfuSystems Holdings Inc	-6.752M
Xtant Medical Holdings Inc	6.434M
Catheter Precision Inc	0.267M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-6.378M
Cash from Investing (Quarterly)	-0.711M
Free Cash Flow	-74.94M
Free Cash Flow Per Share (Quarterly)	-0.1263
Free Cash Flow to Equity (Quarterly)	-7.343M
Free Cash Flow to Firm (Quarterly)	-7.343M
Free Cash Flow Yield	-3.20%